期刊
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
卷 11, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fcimb.2021.702047
关键词
Campylobacter jejuni; microbiota; diarrhea; dysbiosys; human infection model
资金
- Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program by the Uniformed Services University of the Health Sciences (USUHS) [IDCRP-079]
- Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) [NMR-9791/PMB.15.232, NMR-10423]
- Military Infectious Diseases Research Program (MIDRP)
- Navy [6000.RAD1.DA3.A0308]
The study showed that there were statistically significant but minor differences in beta diversity among study participants during the challenge period, and pre-challenge alpha diversity was higher in participants who did not develop campylobacteriosis compared to those who did. However, alpha diversity decreased in all participants after infection. Future studies could explore CHIM studies with inocula more closely resembling natural exposure and field studies involving naturally-occurring enteric infections.
Campylobacter jejuni infection is a leading cause of foodborne disease, common to children, adult travelers, and military populations in low- to middle-income countries. In the absence of a licensed vaccine, efforts to evaluate prophylactic agents are underway. The prophylactic efficacy of a twice-daily, 550 mg dose of the antibiotic rifaximin demonstrated no efficacy against campylobacteriosis in a controlled human infection model (CHIM); however, samples from the CHIM study were utilized to assess how the human gut microbiome responds to C. jejuni infection, and if a 'protective' microbiota exists in study participants not developing campylobacteriosis. Statistically significant, but minor, differences in study participant beta diversity were identified during the challenge period (p = 0.002, R-2 = 0.042), but no significant differences were otherwise observed. Pre-challenge alpha diversity was elevated in study participants who did not develop campylobacteriosis compared to those who did (p < 0.001), but alpha diversity declined in all study participants from the pre-challenge period to post-discharge. Our work provides insight into gut microbiome shifts observed during a C. jejuni CHIM and following antibiotic treatment. This study utilized a high dose of 1.7 x 10(5) colony-forming units of C. jejuni; future work could include CHIM studies performed with inocula more closely mimicking natural exposure as well as field studies involving naturally-occurring enteric infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据